Alnylam Pharmaceuticals
ALNY
#570
Rank
โ‚ฌ36.64 B
Marketcap
274,63ย โ‚ฌ
Share price
0.26%
Change (1 day)
37.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Annual Reports

Thumbnail Alnylam Pharmaceuticals
 Annual Report 2025

Annual Report 2025

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2024

Annual Report 2024

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2023

Annual Report 2023

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2022

Annual Report 2022

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2021

Annual Report 2021

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2019

Annual Report 2019

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2018

Annual Report 2018

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2017

Annual Report 2017

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2010

Annual Report 2010

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2009

Annual Report 2009

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2008

Annual Report 2008

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2007

Annual Report 2007

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2006

Annual Report 2006

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2005

Annual Report 2005

Language: English

View Annual Report
Thumbnail Alnylam Pharmaceuticals
 Annual Report 2004

Annual Report 2004

Language: English

View Annual Report